4/A//SEC Filing
ROSS ROBERT W. 4/A
Accession 0001209191-21-019971
CIK 0001718108other
Filed
Mar 10, 7:00 PM ET
Accepted
Mar 11, 8:00 PM ET
Size
5.7 KB
Accession
0001209191-21-019971
Insider Transaction Report
Form 4/AAmended
ROSS ROBERT W.
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-02-12+484,280→ 484,280 totalExercise: $11.24Exp: 2031-02-12→ Common Stock (484,280 underlying)
Footnotes (1)
- [F1]This Amendment to the Form 4 filed by the reporting person on March 3, 2021 is filed to correct the vesting schedule previously reported in Table II. This option shall become exercisable in equal monthly installments over four years following April 1, 2021, so long as the reporting person remains an employee or other service provider of the Company on such dates.
Documents
Issuer
Surface Oncology, Inc.
CIK 0001718108
Entity typeother
Related Parties
1- filerCIK 0001733077
Filing Metadata
- Form type
- 4/A
- Filed
- Mar 10, 7:00 PM ET
- Accepted
- Mar 11, 8:00 PM ET
- Size
- 5.7 KB